Clinical Trial Update: the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on the efficacy and safety of indobufen combined with low-dose aspirin in different antiplatelet regimens for coronary atheroscl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis

Drugs mentioned

• Aspirin (Aspirin)
• Indobufen (indobufen)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Coronary Atherosclerosis | Phase 4 | Status: UNKNOWN